Sequential hepatic arterial infusion chemotherapy with cisplatin followed by sorafenib versus sorafenib alone in advanced hepatocellular carcinoma
Phase of Trial: Phase II
Latest Information Update: 20 Feb 2017
At a glance
- Drugs Cisplatin (Primary) ; Sorafenib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- Acronyms SCOOP-2
- 17 Feb 2017 Status changed from active, no longer recruiting to completed.
- 30 Sep 2013 Planned end date changed from 1 Jul 2015 to 31 Aug 2016 as reported by University Hospital Medical Information Network - Japan record.
- 12 Aug 2011 New trial record